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The present study aimed to investigate the presence of compounds with antitumor activity 
in the plant Caesalpinia pluviosa var. peltophoroides. From bioactivity guided studies it was 
possible to isolate a new biflavonoid, named caesalpinioflavone, whose chemical structure was 
determined by spectroscopic (1H and 13C nucler magnetic ressonace, homonuclear correlation 
spectroscopy and heteronuclear multiple-bond correlation spectroscopy) and spectrometric (high 
resolution electrospray ionization mass) methods. According to in vitro assays, caesalpinioflavone 
was effective in reducing the cell viability of tumor cell lines A549, MCF7, Hst578T and HTC. 
This effect was consequent of cell cycle arrest in G1/S transition (A549 and MCF7) and cytotoxic 
activity (Hs578T and HTC). Taken together, these data indicate that caesalpinioflavone has a 
promising antitumor activity.
Keywords: Caesalpinia pluviosa var. peltophoroides, biflavonoid, antiproliferative activity, 
cancer
Introduction 
Caesalpinia L. is a genus of Fabaceae plants belonging to 
the Caesalpinioideae sub-family, which is found in tropical 
and subtropical zones, and includes about 500 species, 
most of which have not been investigated in relation to 
their chemical compositions and biological properties. 
Caesalpinia pulcherrima presents emmenagogue and 
abortifacient effects,1 Caesalpinia bonduc (L.) Roxb. 
displays anthelmintic, anticancer and antimalarial 
properties,2 and Caesalpinia sappan has been used as 
an anti-inflammatory agent.2-4 In addition, it has been 
described that sappanchalcone, extracted from C. sappan, 
suppresses oral cancer cell growth and induces apoptosis 
in oral squamous cell carcinoma.5 Several classes of natural 
compounds have been isolated from the Caesalpinia 
genus, including flavonoids, diterpenes, steroids, organic 
acids and sugars.6 Additionally, hydrolysable tannins 
were isolated from Caesalpinia pluviosa (synonym 
Poincianella pluviosa).7 
Considering that Caesalpinia represents a valuable 
source for identifying new chemical compounds with 
therapeutic potential, in this meaning, this study aimed 
the identification of cytotoxic compounds from the 
stem bark methanol extract of Caesalpinia pluviosa var. 
peltophoroides using a bioguided fractionation procedure.
Experimental
General 
All solvents and reagents used were analytically pure. 
Silica gel (Merck, 230-400 mesh) and sephadex LH-20 
(Sigma-Aldrich) were used for column chromatographic 
(CC) separations while silica gel plates (0.25 mm) 
60 PF254 (Merck) were used for analytical thin layer 
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chromatography (TLC). Plates were revealed using 
iodine vapor, vanillin-H2SO4 (3%), 1% FeCl3 in ethanol 
or using ultraviolet radiation (λ = 254 and 356 nm). 
Ultraviolet (UV) measurements were performed using an 
UV-spectrophotometer model UVvis2550 (Shimadzu). 
Melting point was determined using a PFM II Aaker 
apparatus. Infrared (IR) spectrum was obtained on 
Shimadzu IR-Prestig-21 and manipulated with the software 
IR-Solution. 1H (500 MHz) and 13C (125 MHz) nuclear 
magnetic resonance (NMR) spectra were recorded on a 
Bruker 500 MHz apparatus DRX spectrometer (Bruker 
BioSpin, Germany) using CD3OD as solvent. High 
resolution electrospray ionization mass (HRESIMS) 
was obtained using a Bruker MicroTOF II spectrometer 
(Bruker Daltonics, Germany) in negative mode. Optical 
rotation measurement was recorded at 25 °C on a Perkin 
Elmer model 343 polarimeter. High pressure liquid 
chromatography (HPLC) chromatograms were obtained on 
a UFLC Shimadzu 20 A, with a diode array detector (DAD) 
and a VP-ODS (Shimadzu) C-18 column (150 × 4.6 mm, 
5 mm particle size).
Plant material
Stem bark of Caesalpinia pluviosa var. peltophoroides 
was collected on the campus of the federal university of 
Alfenas-UNIFAL/MG (Latitude: 21° 25’ 45’’ south and 
longitude: 45° 56’ 50’’ west). The botanical identification 
was carried out at the federal university of Alfenas by 
professor Dr. Marcelo Polo. A voucher specimen is 
deposited at the herbarium of federal university of Alfenas 
under number of UALF-1634. 
Extraction and isolation 
Fresh stem barks from Caesalpinia pluviosa var. 
peltophoroides were air-dried at 45 °C for 72 h, and the 
ground powder (3.0 kg) was extracted by maceration with 
ethanol (EtOH) at room temperature four times (4 × 7 L). 
The resulting solution was concentrated under reduced 
pressure to yield 100 g of crude EtOH extract, which 
was ressuspended in EtOH/H2O 3:1 and successively 
partitioned using n-hexane and ethyl acetate (EtOAc) 
to afford 62 g of n-hexane and 20 g of EtOAc phases. 
Cytotoxic assay on these both phases indicated that the 
bioactivity was concentrated on EtOAc phase. Part of this 
material (8 g) was subjected to CC on silica gel (135.5 g), 
using increasing amounts of EtOAc in n-hexane as eluent, 
affording twenty five fractions (250 mL each) which were 
pooled in five groups (A-E). Bioactive group C (2.4 g) 
was purified by CC over silica gel (80 g) using mixtures 
of n-hexane/EtOAc as eluent to give 105 fractions (50 mL 
each), which were pooled into 12 groups (C1-C12) being 
bioactivity concentered at group C6. This group (120 mg) 
was subjected to sephadex LH-20 (30 × 2 cm) column 
chromatography using methanol (MeOH) as eluent to 
afford 80 fractions (12 mL each) which were pooled in 
seven groups (C6/1-C6/7). Bioactive group C6/3 (40 mg) 
was composed by caesalpinioflavone as a dark yellow solid.
Caesalpinioflavone: [a]D25 +135 (c 1.0, MeOH); 
mp 227 °C; λmax/nm 264, 311; IR (KBr) nmax/cm-1 3415, 
2952, 1653, 1615, 1512, 1445, 1273, 1242, 839; HRESIMS 
m/z 525.1185 [M-H]- (calcd. to C30H21O9 525.1186). 1H and 
13C NMR spectra (see Table 1).
Cytotoxic assays 
Four tumor cell lines were used in this study: human 
lung carcinoma (A549), human breast carcinomas 
(MCF-7 and Hs578T) and rat hepatocellular carcinoma 
(HTC). The cell cultures were maintained in Dulbecco’s 
modified Eagle’s medium (DMEM, Sigma, CA, USA) 
supplemented with 10% fetal bovine serum (Vitrocell, 
Campinas, Brazil). Cells were grown in a 37 °C humidified 
incubator containing 5% CO2 and seeded into 96 wells 
plates at 5 × 103 (HTC and A549) or 1 × 104 (MCF7 and 
Hs578T) cells per well. After attachment (24 h), the cells 
were treated for 48 h with caesalpinioflavone at different 
concentrations (5 - 160 µmol L-1). The Promega non-
radioactive cell proliferation assay was used to determinate 
the cell viability. This assay measures the amount of 
formazan produced from [3-(4,5-dimethylthiazol-2-yl)-
5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl-2H-
tetrazolium, inner salt, MTS)] by the dehydrogenase 
enzymes of metabolically active cells. Thus, the quantity 
of formazan produced (as measured by the absorbance at 
490 nm) is directly proportional to the number of living cells. 
Absorbance values of the treated cells were compared with 
the absorbance values of the untreated cells. The experiments 
were conducted in triplicate wells and repeated twice. The 
data are presented as the mean ± standard deviation (SD). 
Deoxyribonucleic acid (DNA) content was evaluated by 
flow cytometry (Attune, life technology) after 1 h of staining 
[2-phenylbenzimidazole-5-sulfonic acid (PBSA) containing 
propidium iodide (30 µg mL-1) and RNAase (3 mg mL-1)]. 
The data shown are representative of three independent 
experiments. The results presented in this study correspond 
to the average of three replicates (n = 3) ± standard deviation. 
The results were considered significantly different if they 
had values of p < 0.05, using an ANOVA followed by the 
Scott-Knott test in the SISVAR software.8
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Results and Discussion
Caesalpinioflavone (Figure 1) was isolated as a 
yellow crystalline solid with an optical activity [a]D25 of 
+135° (c 0.1, MeOH) and a melting point of 227 °C. The 
molecular formula was established as C30H22O9 based on 
the negative mode HRESIMS (Figure S1), which exhibited 
the deprotonated molecule [M-H]- at m/z 525.1185 (calcd. 
525.1186). The IR spectrum (Figure S2) showed strong 
absorptions at 3415 cm-1 (OH), 2952 cm-1 (CH=CH), 
and 1653/1615 cm-1. The UV spectrum displayed 
absorptions with λmax at 264 and 311 nm, characteristic 
of flavonoids. The 13C NMR spectrum (Table 1) showed 
carbonyl resonances at δC 203.5 (C-4”) and 182.6 (C-4), 
oxygenated carbons at δC 166.3 (C-7), 165.9 (C-5), 165.8 
(C-2), 163.3 (C-9”), 163.0 (C-7”), 161.1 (C4’), 159.3 
(C-9), 156.9 (C-4”’), the p-substituted aromatic carbons 
at δC 131.5 (C-3’ and C-5’), 131.4 (C-3”’ and C-5”’), 
116.3 (C-2’ and C-6’), 116.1 (C-2”’ and C-6”’), as well 
as saturated carbons at δC 49.2 (C-2”) and δC 36.0 (C-3”). 
The presence of characteristic carbon signals of flavones 
and chalcones associated to HRESIMS, the occurrence of 
a biflavonoid derivative was defined.9 1H NMR spectrum of 
caesalpinioflavone (Table 1) showed signals ranging from 
δH 7.00 to 6.50 (8H) which referred to the hydrogen atoms 
of two p-substituted aromatic rings. These data, associated 
to the presence of doublets at δH 6.24 (d, J 2.5 Hz, H-8) and 
δH 6.19 (d, J 2.5 Hz, H-6), indicated a subunit of apigenin.10 
Other signals were observed at δH 7.26 (d, J 8.7 Hz, H-5”), 
6.19 (d, J 2.5 Hz, H-8”) and 6.15 (dd, J 8.7 and 2.5 Hz, 
H-6”), indicating the presence of a 1,2,4-trisubstituted 
aromatic ring. Signals at δH 4.69 (dd, J 7.5 and 6.5 Hz, 
H-2”), 3.47 (dd, J 14.0 and 6.5 Hz, H-3a”) and 3.09 
(dd, J 14.0 and 7.5 Hz, H-3b”) indicated the occurrence 
of a 4,2’,4’-trihydroxychalcone unit. The homonuclear 
correlation spectroscopy (COSY) couplings between 
the signals at δH 6.19 (d, J 2.5 Hz, H-6) with δH 6.24 (d, 
J 2.5 Hz, H-8), δH 6.15 (dd, J 8.7 and 2.5 Hz, H-6”) with 
δH 7.26 (d, J 8.7 Hz, H-5”) and δH  6.19 (d, J 2.5 Hz, H-8”), 
and δH 4.69 (H-2”) with δH  3.47 (H-3”a) and δH 3.09 
(H-3”b) confirmed the proposed substructures. Finally, 
the heteronuclear multiple-bond correlation spectroscopy 
(HMBC) spectrum showed the correlation of the signal at 
δH 4.69 (H-2”) with those at δC 182.6 (C-4), 36.0 (C-3”), 
165.8 (C-2) and 203.5 (C-4”), and the correlations of 
the signals at δH 3.47/3.09 (H-3”) with those at δC 36.0 
(C-3”) and 203.5 (C-4”), which confirmed the connection 
between C-2” and C-3 in the biflavonoid structure 
(Figure 2 and Figures S3-S7). All the observed correlations 
are shown in Table 1. The configuration at C-2” was 
not assigned.
The cytotoxic potential of caesalpinioflavone was 
determined by MTS assay, and the results showed a 
drastic reduction of the cell viability in cells treated with 
caesalpinioflavone in concentrations upward of 40 mmol L-1 
(Figure 3). Among the cell lines studied, the hepatoma 
cell line (HTC) was the most responsive to treatment 
(IC50 value = 48.00 ± 1.60 mmol L-1). When HTC cells were 
treated under the same conditions with cisplatin, a powerful 
cytotoxic anticancer agent, the IC50 value was found to be 
38.53 ± 1.49 µmol L-1. IC50 values found for the other cell 
lines were 121 ± 9.7 mmol L-1 (MCF7), 108 ± 7.6 mmol L-1 
(A549) and 97.65 ± 3.2 mmol L-1 (Hs578T). These results 
indicate that caesalpinioflavone displays antiproliferative 
activity against HTC cells, which is in agreement with 
recent studies reporting that different flavonoids can 
Figure 1. Chemical structure of caesalpinioflavone, a novel biflavonoid 
isolated from the stem bark of Caesalpinia pluviosa var. peltophoroides.
Figure 2. Relevant HMBC correlations (H → C) of caesalpinioflavone.
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exert growth inhibition and/or cytotoxic activities on 
hepatocellular carcinoma cell lines.9-12 
The images obtained by phase contrast microscopy 
(Figure 4) show the morphological features of the cell 
lines studied. The images clearly show lower cell densities 
in the treated cultures compared to the control cultures. 
To investigate whether the cytotoxic effects were a 
consequence of cell death induction or cell cycle arrest, we 
performed the cell cycle analysis by DNA quantification. 
Thus, the cultures were treated with caesalpinioflavone 
at 40 mmol L-1 and 80 mmol L-1, and the samples were 
analyzed by flow cytometry. The results showed that the 
effects of caesalpinioflavone on the cell cycle progression 
were concentration-dependent, and they varied depending 
on the cell type (Figure 5).
In MCF7, we observed cell cycle arrest in the G1/S 
transition (at 40 mmol L-1) and the G2/M arrest (at 
80 mmol L-1). In A549, both concentrations caused G1/S 
transition inhibition. It has been reported that phenolic 
compounds present pro-oxidant activity when used at 
high concentrations,13-15 and may contribute for activating 
proteins associated to cell cycle control such as p53, p21 
and GADD45.16,17 In the present work, the cell lines with 
wild p53 displayed inhibition of the G1/S transition as a 
consequence of treatment, suggesting that the p53 pathway 
could be activated by caesalpinioflavone.
In Hs578T and HTC cells, an increased subG1 
population was observed in addition to cell cycle arrest. 
When concentrations around the IC50 were used (80 mmol L-1 
and 40 mmol L-1 for Hs578T and HTC, respectively) cell 
cycle arrest in G2/M was observed. In these cell lines, at the 
same concentrations, the subG1 populations were 2.5-fold 
(Hs578T) and 5-fold (HTC) higher than in control cultures. 
Table 1. NMR data for caesalpinioflavone in CD3OD 
Position δC δH (m, J / Hz) HMBC
2 165.8 - H2”
3 120.9 - H2”/H3”
4 182.6 - H2”
5 165.9 - H6
6 100.1 6.19 (d, 2.5) H8
7 166.3 - H8
8 94.6 6.24 (d, 2.5) H6
9 159.2 - H8
10 104.9 - H8
1’ 124.6 - -
2’; 6’ 116.3 6.82 (d, 8.7) -
3’; 5’ 131.5 7.02 (d, 8.7) -
4’ 161.1 - H3’/H5’
2” 49.2 4.69 (dd, 7.5; 6.5) H3”
3a” 36.0 3.46 (dd, 14.0; 6.5) H3b”/H2”
3b” 36.0 3.09 (dd, 14.0; 7.5) H3a”/H2”
4” 203.5 - H2”/H3”
5” 132.1 7.25 (d, 9.0) H6”
6” 108.5 6.15 (dd, 9.0; 2.5) H5”/H8”
7” 163.0 - H8”
8” 103.9 6.19 (d, 2.5) H6”
9” 163.3 - H8”
10” 113.7 - H5
1”’ 132.1 - H2”/H2”’
2”’; 6”’ 116.1 6.64 (d, 8.5) -
3”’; 5”’ 131.4 6.95 (d, 8.5) -
4”’ 156.8 - H3”’/H5”’
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Figure 3. Relative cell viability of caesalpinioflavone against tumor cell 
lines A549, HCT, MCF7 and Hs578T, obtained by the MTS assay. 
Figure 4. Images obtained by phase contrast microscopy showing the 
morphological features of the tumor cell lines A549, MCF7, Hs578T 
and HTC, after 48 h of treatment with caesalpinioflavone at 40 mmol L-1 
and 80 mmol L-1. 
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You et al.18 demonstrated that the increase in the subG1 
population in human PC-3 (prostate cancer) cell cultures 
after treatment with ginkgetin (a biflavonoid) for 24 h was 
due to apoptosis induction. Phenolic compounds, such as 
caffeic acid phenethyl ester, induced apoptosis in glioma 
cells by the activation of the p53 pathway whereas cinnamic 
acid was effective in inducing apoptosis in melanoma cells 
by different pathways.12,19,20 The results obtained in the 
present work showed that caesalpinioflavone inhibits cell 
proliferation of MCF7 and A549 cells, and has cytotoxic 
activity against Hs578T and HTC cell lines. 
Conclusions
A novel biflavonoid, named as caesalpinioflavone was 
isolated from the stem bark of Caesalpinia pluviosa var. 
peltophoroides. Caesalpinioflavone reduced cell viability 
of tumor cell lines A549, MCF7, Hst578T and HTC, as 
consequence of cell cycle arrest in G1/S transition (A549 
and MCF7) and cytotoxic activity (Hs578T and HTC). 
Taken together, these data indicate that caesalpinioflavone 
has a promising antitumor activity.
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Supplementary information, including 1H NMR, 
13C NMR, COSY, HSQC, and HMBC spectra, as well 
as mass and IR spectra, are available free of charge at 
http://jbcs.org.br as a PDF file.
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